Operating CF
$715M
Capex
-$257M
Free Cash Flow
$458M
FCF Margin
+64.0%
Cash flow waterfall for West Pharmaceutical Services (WST) — TTM through Q1 2026
Free cash flow: $458M
Cash flow breakdown for West Pharmaceutical Services (WST) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $715M | $715M |
| Capital Expenditure | -$257M | $458M |
| Free Cash Flow | $458M | $458M |
| Share Buybacks | -$298M | $160M |
| Dividends Paid | -$61.8M | $97.8M |
| Other Financing & FX | $19.4M | $117M |
| Net Cash Increase | $117M | $117M |
- Operating Cash Flow$715M
- Capital Expenditure-$257M
- Free Cash Flow$458M
- Share Buybacks-$298M
- Dividends Paid-$61.8M
- Other Financing & FX$19.4M
- Net Cash Increase$117M
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks1.65% TTM
- Dividend Profile0.24% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.